158 related articles for article (PubMed ID: 8823262)
1. Management of thyroid carcinoma with radioactive 131I.
Paryani SB; Chobe RJ; Scott W; Wells J; Johnson D; Kuruvilla A; Schoeppel S; Deshmukh A; Miller R; Dajani L; Montgomery CT; Puestow E; Purcell J; Roura M; Sutton D; Mallett R; Peer J
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):83-6. PubMed ID: 8823262
[TBL] [Abstract][Full Text] [Related]
2. Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation.
Lin JD; Chao TC; Huang MJ; Weng HF; Tzen KY
Am J Clin Oncol; 1998 Feb; 21(1):77-81. PubMed ID: 9499265
[TBL] [Abstract][Full Text] [Related]
3. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
4. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
[TBL] [Abstract][Full Text] [Related]
5. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
6. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
Allan E; Owens SE; Waller ML
Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
[TBL] [Abstract][Full Text] [Related]
7. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
Lin JD; Kao PF; Chao TC
Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
[TBL] [Abstract][Full Text] [Related]
8. Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer.
Vermiglio F; Violi MA; Finocchiaro MD; Baldari S; Castagna MG; Moleti M; Mattina F; Pio Lo Presti V; Bonanno N; Trimarchi F
Thyroid; 1999 Apr; 9(4):387-91. PubMed ID: 10319946
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid cancer: radioiodine following lobectomy - a clinical feasibility study.
Hoyes KP; Owens SE; Millns MM; Allan E
Nucl Med Commun; 2004 Mar; 25(3):245-51. PubMed ID: 15094442
[TBL] [Abstract][Full Text] [Related]
10. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
[TBL] [Abstract][Full Text] [Related]
12. Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan.
Hommel I; Pieters GF; Rijnders AJ; van Borren MM; de Boer H
Neth J Med; 2016 May; 74(4):152-7. PubMed ID: 27185773
[TBL] [Abstract][Full Text] [Related]
13. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of ablation with low radioiodine activity in patients with papillary thyroid carcinoma and predictive value of postoperative nonstimulated thyroglobulin.
Rosario PW; Mourão GF; Calsolari MR
Nucl Med Commun; 2016 Oct; 37(10):1024-9. PubMed ID: 27306852
[TBL] [Abstract][Full Text] [Related]
15. [Prospective therapy study in differentiated thyroid carcinoma].
Gemsenjäger E; Heitz P; Martina B
Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
[TBL] [Abstract][Full Text] [Related]
16. Effect of postoperative 131I treatment on thyroglobulin measurements in the follow-up of patients with thyroid cancer.
Baskin HJ
Thyroid; 1994; 4(3):239-42. PubMed ID: 7833657
[TBL] [Abstract][Full Text] [Related]
17. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine in the treatment of hereditary medullary carcinoma of the thyroid.
Nieuwenhuijzen Kruseman AC; Bussemaker JK; Frölich M
J Clin Endocrinol Metab; 1984 Sep; 59(3):491-4. PubMed ID: 6746863
[TBL] [Abstract][Full Text] [Related]
19. Radioactive iodine in the treatment of medullary carcinoma of the thyroid.
Saad MF; Guido JJ; Samaan NA
J Clin Endocrinol Metab; 1983 Jul; 57(1):124-8. PubMed ID: 6853671
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of patients to detect recurrent thyroid carcinoma.
Grigsby PW; Baglan K; Siegel BA
Cancer; 1999 Feb; 85(4):945-51. PubMed ID: 10091774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
